I'm confused...this seems to be another study The study was conducted by an independent Contract Research Organisation to assess the in-vitro efficacy of R327 against all ESKAPE pathogen bacterial strains. R327 is a broad-spectrum synthetic
anti-infective that has potential to address the urgent global health threat posed by antibiotic resistant
superbugs and emerging viral pathogens.
So it's not ferrets etc. But no matter. It's all GOOD!!
Ann: Positive Data on RECCE 327 Against All Six ESKAPE Pathogens, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 32.8¢ | 29.0¢ | $78.39K | 251.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 916 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 114230 | 1 |
View Market Depth
| Last trade - 15.59pm 25/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |